Main Session
Sep
27
SS 05 - Advances in Radiation Response and Microenvironment
125 - Phase I Trial with Expansion Cohort of DNA-PK Inhibitor Peposertib and Intensity Modulated Radiation Treatment (IMRT) in Cisplatin-Ineligible Patients with Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Presenter(s)
Michael Samuels, MD - University of Miami Miller School of Medicine, Miami, FL